The Heart -- A US Food and Drug Administration advisory panel voted 7 to 5 in favor of approving a device for closure of the left atrial appendage (LAA) as an alternative to long-term warfarin therapy for the prevention of stroke in warfarin-eligible patients with nonvalvular atrial fibrillation (AF).
